Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations
Clinical trial NCT03842228 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03842228
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2024-07-29
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.